Pioneering Breakthrough Therapies for Neuropsychiatric Disorders

About Us

Amorsa is dedicated to improving the health and well-being of patients affected by neuropsychiatric disorders.

Technology Platform

Building on ketamine’s proven success as a rapid-acting antidepressant, Amorsa is developing novel oral therapeutic agents based on proprietary ketamine analogs.

Target Applications

Pioneering breakthrough treatments for neuropsychiatric disorders including treatment-resistant depression, PTSD and obsessive-compulsive disorder.

Latest News